Heinrich Haas
professor
Professor Dr. Heinrich Haas is a leading researcher from the British company NeoVac, co-authoring an influential perspective on the design and stability of lipid nanoparticles, which play a crucial role in the efficacy and safety of future mRNA vaccines.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Slovenia:
Heinrich Haas is a co-author of the article and a professor at NeoVac in the UK.
7